Delivery Order SPE2DB20D1050-SPE2DB25FH81P
Award Date 8/4/25
Potential Completion Date 8/25/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,241.54 delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a direct procurement of pharmaceutical supplies for federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, valued at $2,161.02, with an ultimate completion date of August 21, 2025. This is a firm fixed price, non-set-aside delivery order issued on July 31, 2025, under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp for Xolair 150 mg/mL syringes, with an ultimate completion date of August 21, 2025. This non-set-aside, firm fixed-price delivery order represents a competitively awarded pharmaceutical supply transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $25,932.24 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,440.70 for XOLAIR 150 mg/mL syringes under a firm fixed price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 26, 2025. This delivery order represents a non-competitive, non-set-aside procurement and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $7,203.40 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded on July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued without a set-aside designation, indicating it was competitively awarded. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $2,881.36 delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes, with an ultimate completion date of August 13, 2025. This firm fixed price contract, awarded July 23, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xolair 150 mg/mL syringes, valued at $10,805.10. This is a firm fixed-price delivery order with a completion date of August 20, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xolair 150 mg/ml syringes, with a contract ceiling value of $5,402.58 and an ultimate completion date of August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $8,644.08 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania....